Dechra Pharmaceuticals posts strong first quarter results
23rd Oct 2015 07:18
(ShareCast News) - Dechra Pharmaceuticals has posted a strong first quarter update, with a substantial increase in revenue. The FTSE 250 listed company posted a trading update on Friday for the three months to 30 September. Group revenue for the first quarter increased by 21% at a constant exchange
Read moreDechra Pharmaceuticals posts higher annual revenue, despite currency headwinds
7th Sep 2015 08:05
(ShareCast News) - Dechra Pharmaceuticals said its performances in the financial year were in line with expectations, although it remained subject to currency headwinds. In the 12 months to 30 June, the FTSE 250 group posted a 20.5% year-on-year increase in pre-tax profit to £25.8m, while revenue ed
Read moreDechra to take major stake in Genera
3rd Aug 2015 09:09
(ShareCast News) - Croatian animal health supplier Dechra has offered €51.4m for a majority stake in pharmaceutical business Genera. The move will get Dechra into the poultry vaccine market with the potential to explore vaccines for other animals, the company said. Dechra said it would buy 63.3% of
Read moreDechra Pharmaceuticals on track, US sales up 64%
8th Jul 2015 08:05
Vet chemist Dechra Pharmaceuticals said it was on track to meet expectations due to stronger revenues. In a trading update the company said for the year to 30 June, group revenue was up 10% at constant exchange rates. North American revenues were up by 60% at constant exchange rates while European
Read moreDechra Pharmaceuticals reports strong Q3 revenues thanks to jump in US sales
28th Apr 2015 09:07
Veterinary products manufacturer Dechra Pharmaceuticals said on Tuesday its full-year results will be in line with managements expectations after reporting an increase in revenues during the third quarter. Dechra saw its revenues up 14.3% at constant exchange rate driven by strong pre-Easter orderin
Read moreTuesday tips round-up: Bunzl, Dechra Pharmaceuticals
24th Feb 2015 16:45
Despite foreign exchange headwinds and the economic slowdown on the continent, Bunzl continues to sport a multiple of over 21 times earnings. The company, which distributes a range of workaday cleaning goods to firms around the world, is now the 63rd largest on the stock market. Despite having alrea
Read moreFTSE 250 movers: Ladbrokes hit by job cuts, DS Smith boosted by Duropack acquisition
23rd Feb 2015 16:33
Ladbrokes topped the fallers after it was reported on Sunday the company would be announcing the closure of roughly 50 betting shops due to the challenge of tax rises and regulation. The company is expected to outline the plans at its full-year results presentation on Thursday. Premier Oil was lower
Read moreDechra Pharmaceuticals revenues rise on US expansion
14th Jan 2015 09:48
Veterinary drug maker Dechra Pharmaceuticals has unveiled a glossy-coated first-half trading update, in line with expectations following a year of expansion in the US. The FTSE 250 group's revenues increased by 6%, impacted by a weaker first half due to adverse weather conditions and supply issues f
Read moreMonday broker round-up UPDATE
27th Oct 2014 10:05
Aquarius Platinum: Deutsche Bank shifts target price from 28p to 30p and maintains a buy recommendation. Dechra Pharmaceuticals: FinnCap ups target price from 800p to 840p and reiterates a buy recommendation. easyJet: Morgan Stanley moves target price from 1650p to 1665p leaving its overweight rati
Read moreFriday broker round-up UPDATE
24th Oct 2014 10:11
Advanced Medical Solutions: Oriel initiates with a target price of 135p and a buy recommendation. African Barrick Gold: JP Morgan moves target price from 300p to 310p maintaining its overweight rating. Canaccord Genuity reduces target price from 330p to 275p keeping a buy recommendation. Numis moves
Read moreDechra Pharmaceuticals gets year off to a good start with strong Q1
24th Oct 2014 08:04
Dechra Pharmaceuticals has got its financial year off to a good start with a 6% increase in revenue during the first quarter, in line with expectations. It said, however, that the performance came against a soft period last time, which was adversely affected by the phasing of export orders and suppl
Read moreThursday broker round-up UPDATE
2nd Oct 2014 10:11
BAE Systems: Investec downgrades from hold to sell with a target price of 430p. British Sky Broadcasting: Credit Suisse ups target price from 600p to 630p and reiterates an underperform rating. Cobham: Investec lowers target price from 290p to 280p and stays with its reduce rating. Consort Medical
Read moreLondon midday: UK stocks sink on fears over Scottish referendum, Ukraine
8th Sep 2014 11:36
Concerns surrounding the upcoming referendum on Scottish independence and a fragile ceasefire agreement in Ukraine were weighing heavily on UK stocks on Monday. London's FTSE 100 was trading down 1% at 6,789 by midday. The index has not closed below the 6,800 mark since 22 August when it settled at
Read moreLondon open: AB Foods leads UK stocks lower early on
8th Sep 2014 08:29
UK stocks fell on Monday morning on the back of uncertainty surrounding the ceasefire in Ukraine and the Scottish referendum. The FTSE 100 was trading 0.3% lower at 6,834 in early trading, with Associated British Foods leading the fallers after an underwhelming pre-close update. Markets were in the
Read moreUS division helps drive 2.3% rise in annual growth at Dechra Pharma
8th Jul 2014 09:23
Dechra Pharmaceuticals said annual growth of 2.3% was driven by its US business, where its key products delivered a strong performance. In the year ended June 30th, the FTSE 250-listed specialist veterinary pharma group saw growth across all of its European Union markets, with the exception of the
Read more